![]() |
|
|
MS Brodie, RD Trifunovic and SA Shefner
Department of Physiology and Biophysics, University of Illinois at Chicago, College of Medicine, USA.
Neurons of the ventral tegmental area of Tsai (VTA) are important in mediation of the rewarding effects of drugs of abuse, including ethanol. We have demonstrated previously that ethanol excites neurons of the VTA recorded in a brain slice preparation. In the present study, we tested the interaction between serotonin and ethanol on putative dopamine neurons of the VTA. As reported previously, ethanol (20-160 mM) excited VTA neurons in a concentration-dependent manner. Serotonin (1-50 microM) produced only minor increases or decreases of the firing rate. In the presence of serotonin, the potency of ethanol was increased significantly. This potentiation of ethanol excitation by serotonin was seen in VTA slices taken from Sprague-Dawley, Fischer 344 and Lewis rats. The effect of 160 mM ethanol on VTA neurons from Fischer 344 rats, for example, was increased from 38.5 +/- 6.1% before serotonin to 77.4 +/- 16.7% after administration of 10 microM serotonin. Two serotonergic agonists, (+/-)-2,5-dimethoxy-4- iodoamphetamine hydrochloride and alpha-methylserotonin, also potentiated the ethanol-induced excitation. The action of serotonin to increase the potency of ethanol to excite VTA neurons may be an important factor in the rewarding effects of ethanol, and might be exploited to develop effective pharmacotherapeutic agents for the treatment of alcohol craving.
This article has been cited by other articles:
![]() |
Z. A. Rodd, R. L. Bell, V. K. McQueen, M. R. Davids, C. C. Hsu, J. M. Murphy, T.-K. Li, L. Lumeng, and W. J. McBride Prolonged Increase in the Sensitivity of the Posterior Ventral Tegmental Area to the Reinforcing Effects of Ethanol following Repeated Exposure to Cycles of Ethanol Access and Deprivation J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 648 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Thielen, E. A. Engleman, Z. A. Rodd, J. M. Murphy, L. Lumeng, T.-K. Li, and W. J. McBride Ethanol Drinking and Deprivation Alter Dopaminergic and Serotonergic Function in the Nucleus Accumbens of Alcohol-Preferring Rats J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 216 - 225. [Abstract] [Full Text] |
||||
![]() |
Z. A. Rodd, R. I. Melendez, R. L. Bell, K. A. Kuc, Y. Zhang, J. M. Murphy, and W. J. McBride Intracranial Self-Administration of Ethanol within the Ventral Tegmental Area of Male Wistar Rats: Evidence for Involvement of Dopamine Neurons J. Neurosci., February 4, 2004; 24(5): 1050 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, E. B. Bunney, S. B. Appel, and M. S. Brodie Serotonin Reduces the Hyperpolarization-Activated Current (Ih) in Ventral Tegmental Area Dopamine Neurons: Involvement of 5-HT2 Receptors and Protein Kinase C J Neurophysiol, November 1, 2003; 90(5): 3201 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Bunney, S. B. Appel, and M. S. Brodie Electrophysiological Effects of Cocaethylene, Cocaine, and Ethanol on Dopaminergic Neurons of the Ventral Tegmental Area J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 696 - 703. [Abstract] [Full Text] |
||||
![]() |
E. B. Bunney, S. B. Appel, and M. S. Brodie Cocaine Potentiates Ethanol-Induced Excitation of Dopaminergic Reward Neurons in the Ventral Tegmental Area J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 383 - 389. [Abstract] [Full Text] |
||||
![]() |
M. S. Brodie, M. A. McElvain, E. B. Bunney, and S. B. Appel Pharmacological Reduction of Small Conductance Calcium-Activated Potassium Current (SK) Potentiates the Excitatory Effect of Ethanol on Ventral Tegmental Area Dopamine Neurons J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 325 - 333. [Abstract] [Full Text] |
||||
![]() |
M. Giorgetti, J. I. Javaid, J. M. Davis, E. Costa, A. Guidotti, S. B. Appel, and M. S. Brodie Imidazenil, a Positive Allosteric GABAA Receptor Modulator, Inhibits the Effects of Cocaine on Locomotor Activity and Extracellular Dopamine in the Nucleus Accumbens Shell Without Tolerance Liability J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 58 - 66. [Abstract] [Full Text] |
||||